Throughout its history, the United States has led the world in protecting intellectual property (IP)…
CFIF on Twitter CFIF on YouTube
Free Webinar: Debunking Patent & Antitrust Myths -- Register Now

Throughout its history, the United States has led the world in protecting intellectual property (IP) rights. On that foundation, we’ve also led the world in artistic, commercial and scientific innovation, particularly with lifesaving medicines and vaccines.

Yet patent rights are under increasing assault, with anti-patent activists charging pharmaceutical makers with "antitrust" violations for utilizing and building upon their patents for the greater good. Their rhetoric and false critiques under the guise of "antitrust" typically rely upon an array of misleading and pejorative labels, to the point where they take on a meaning that bears no resemblance to reality.

The Center for Individual Freedom (CFIF) and IPWatchdog, Inc., have partnered up to offer a free webinar conversation that…[more]

August 03, 2021 • 10:07 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
CFIF Submits Formal Comment on NIST Proposed Rule Regarding Bayh-Dole Act of 1980 Print
By CFIF Staff
Monday, April 12 2021

Last week, the Center for Indvidiual Freedom (CFIF) submitted a formal Comment with the U.S. Commerce Department's National Institute of Standards and Technology (NIST) on its Proposed Rule regarding the Bayh-Dole Act of 1980, which granted universities, nonprofit organizations and small business the right to patent and license inventions funded partly by federal funding. 

The Economist magazine called the Bayh-Dole Act "Possibly the most inspired piece of legislation to be enacted in America over the past half century," and rightfully so.  It unleashed a tidal wave of hundreds of thousands of patents issued to American universities and research institutes since then. 

On that basis, CFIF supports the Proposed Rule to the extent that it advances the provisions and intent of Bayh-Dole, with the caveat that insertion of the terms "exclusively" and "of the contractor" in the Proposed Rule's text may open the door for advocates of drug price controls to suggest that business decisions of pharmaceutical innovators regarding the pricing of commercial goods and services arising from the practical application of inventions may serve as one basis for exercising march-in rights.  Neither the text nor the intent of the Bayh-Dole Act allow that, as namesake Senators Bayh and Dole themselves pointed out in a joint statement to The Washington Post

On that basis we urge that the Proposed Rule omit those terms.  We must ensure that Bayh-Dole's four-decade legacy of incredible success continues, without the looming threat that activists may attempt to use it to impose destructive drug price controls on American consumers.

Read CFIF's comment here (PDF).

Related Articles :
Quiz Question   
How many states mandate vaccine immunization for children for some infectious diseases as a requirement to enroll in public schools?
More Questions
Notable Quote   
 
"The bad judgment calls continue to pile up just seven months into the Biden administration. President Joe Biden's tenure is increasingly characterized by poor personnel choices, ethical lapses, and disastrous policy decisions. Simply put, judgement is Biden's biggest flaw.Foreshadowing what would become a pattern, Biden began his presidency by selecting the unpopular former presidential candidate…[more]
 
 
—Jason Chaffetz, Fox News Contributor, Distinguished Fellow for the Government Accountability Institute and Former Chairman of the House Oversight and Government Reform Committee
— Jason Chaffetz, Fox News Contributor, Distinguished Fellow for the Government Accountability Institute and Former Chairman of the House Oversight and Government Reform Committee
 
Liberty Poll   

What is your level of trust regarding CDC guidance regarding Covid-19?